These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 21871986)

  • 21. One-stage resection for Bismuth type IV hilar cholangiocarcinoma with high hilar resection and parenchyma-preserving strategies: a cohort study.
    Tan JW; Hu BS; Chu YJ; Tan YC; Ji X; Chen K; Ding XM; Zhang A; Chen F; Dong JH
    World J Surg; 2013 Mar; 37(3):614-21. PubMed ID: 23283218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.
    Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
    Hepatogastroenterology; 2002; 49(44):311-6. PubMed ID: 11995440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgery for recurrent biliary carcinoma: results for 27 recurrent cases.
    Noji T; Tsuchikawa T; Mizota T; Okamura K; Nakamura T; Tamoto E; Shichinohe T; Hirano S
    World J Surg Oncol; 2015 Feb; 13():82. PubMed ID: 25884694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of lymphadenectomy for long-term outcomes in node-negative intrahepatic cholangiocarcinoma: A multicenter study.
    Yoh T; Cauchy F; Le Roy B; Seo S; Taura K; Hobeika C; Dokmak S; Farges O; Gelli M; Sa Cunha A; Adam R; Uemoto S; Soubrane O
    Surgery; 2019 Dec; 166(6):975-982. PubMed ID: 31421869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma.
    Wakai T; Shirai Y; Moroda T; Yokoyama N; Hatakeyama K
    Cancer; 2005 Mar; 103(6):1210-6. PubMed ID: 15685618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prognostic role of lymphovascular invasion and lymph node metastasis in perihilar and intrahepatic cholangiocarcinoma.
    Lurje G; Bednarsch J; Czigany Z; Lurje I; Schlebusch IK; Boecker J; Meister FA; Tacke F; Roderburg C; Den Dulk M; Gaisa NT; Bruners P; Neumann UP
    Eur J Surg Oncol; 2019 Aug; 45(8):1468-1478. PubMed ID: 31053477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surgical treatment of mass-forming intrahepatic cholangiocarcinoma: an 11-year Western single-center experience in 107 patients.
    Yedibela S; Demir R; Zhang W; Meyer T; Hohenberger W; Schönleben F
    Ann Surg Oncol; 2009 Feb; 16(2):404-12. PubMed ID: 19037702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic factors after surgical resection for intrahepatic, hilar, and distal cholangiocarcinoma.
    Murakami Y; Uemura K; Sudo T; Hashimoto Y; Nakashima A; Kondo N; Sakabe R; Ohge H; Sueda T
    Ann Surg Oncol; 2011 Mar; 18(3):651-8. PubMed ID: 20945107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathological factors impact the survival outcome following the resection of combined hepatocellular carcinoma and cholangiocarcinoma.
    Yap AQ; Chen CL; Yong CC; Kuo FY; Wang SH; Lin CC; Liu YW; Lin TL; Li WF; Millan CA; Wang CC
    Surg Oncol; 2013 Mar; 22(1):55-60. PubMed ID: 23102615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma.
    Jarnagin WR; Fong Y; DeMatteo RP; Gonen M; Burke EC; Bodniewicz BS J; Youssef BA M; Klimstra D; Blumgart LH
    Ann Surg; 2001 Oct; 234(4):507-17; discussion 517-9. PubMed ID: 11573044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival rate of intrahepatic cholangiocarcinoma patients after surgical treatment in Thailand.
    Sriputtha S; Khuntikeo N; Promthet S; Kamsa-Ard S
    Asian Pac J Cancer Prev; 2013; 14(2):1107-10. PubMed ID: 23621195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic factors in patients with recurrent intrahepatic cholangiocarcinoma after curative resection: A retrospective cohort study.
    Ohira M; Kobayashi T; Hashimoto M; Tazawa H; Abe T; Oshita A; Kohashi T; Irei T; Oishi K; Ohdan H;
    Int J Surg; 2018 Jun; 54(Pt A):156-162. PubMed ID: 29730072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Locoregional recurrence after curative intent resection for intrahepatic cholangiocarcinoma: implications for adjuvant radiotherapy.
    Song S; Kim K; Chie EK; Kim S; Park HJ; Yi NJ; Suh KS; Ha SW
    Clin Transl Oncol; 2015 Oct; 17(10):825-9. PubMed ID: 26041722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of staging systems to survival in patients with resected hilar cholangiocarcinoma.
    Zaydfudim VM; Clark CJ; Kendrick ML; Que FG; Reid-Lombardo KM; Donohue JH; Farnell MB; Nagorney DM
    Am J Surg; 2013 Aug; 206(2):159-65. PubMed ID: 23746658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome after liver resection for primary and recurrent intrahepatic cholangiocarcinoma.
    Nickkholgh A; Ghamarnejad O; Khajeh E; Tinoush P; Bruckner T; Kulu Y; Mieth M; Goeppert B; Roessler S; Weiss KH; Hoffmann K; Büchler MW; Mehrabi A
    BJS Open; 2019 Dec; 3(6):793-801. PubMed ID: 31832586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experience of surgical resection for hilar cholangiocarcinomas at a Japanese single cancer institute.
    Nanashima A; Tobinaga S; Abo T; Machino R; Takeshita H; Nonaka T; Hidaka S; Tanaka K; Kunizaki M; Sawai T; Yasutake T; Nagayasu T
    Hepatogastroenterology; 2012; 59(114):347-50. PubMed ID: 22353497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma.
    Su CH; Tsay SH; Wu CC; Shyr YM; King KL; Lee CH; Lui WY; Liu TJ; P'eng FK
    Ann Surg; 1996 Apr; 223(4):384-94. PubMed ID: 8633917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience.
    Lee SG; Song GW; Hwang S; Ha TY; Moon DB; Jung DH; Kim KH; Ahn CS; Kim MH; Lee SK; Sung KB; Ko GY
    J Hepatobiliary Pancreat Sci; 2010 Jul; 17(4):476-89. PubMed ID: 19851704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concomitant Precise Hemihepatectomy to Improve the Efficacy of Surgical Treatment for Hilar Cholangiocarcinoma: Analysis of 38 Cases.
    Wang L; Geng ZM; Song XG; Zhao YL; Noor H; Shi L; Liu QG
    Hepatogastroenterology; 2014 Jun; 61(132):927-32. PubMed ID: 26158143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histologic bile duct invasion by a mass-forming intrahepatic cholangiocarcinoma.
    Hirohashi K; Uenishi T; Kubo S; Yamamoto T; Tanaka H; Shuto T; Yamasaki O; Horii K; Kinoshita H
    J Hepatobiliary Pancreat Surg; 2002; 9(2):233-6. PubMed ID: 12140612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.